Articles by Patrick Angelastro - Pharmaceutical Executive


Articles by Patrick Angelastro

Special Report: Platform Drugs—Marketing Your Opportunities

May 1, 2008

Tracking business by indication is critical for evaluating market performance and making accurate resource allocations

No Margin for Error

Companies that will be forced to cut back on sales and marketing spending must focus on value, not volume. Here's how to reduce your spend where it matters the least.
Sep 1, 2005

When rebate strategies are coupled with sales force and DTC spending, it results in "margin-negative" business—that is, sales that bring in less than the marginal cost of selling, promoting, and manufacturing the drug.


Click here